Dermatitis atopic
Not yet recruitingStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
- Disease:Dermatitis atopic
- Substances:Img-007
Germany- Participants:18–64 years · 65+ years
- Substances:Img-007
- Sponsor:Inmagene LLC
Rare diseases
Investigational molecules
Locations
Back to Germany297 clinical trials in Augsburg, Germany across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on breast cancer, lung cancer, and lymphoma treatments. Studies evaluating novel therapeutic approaches including targeted therapies and immunotherapy combinations.
Several trials are investigating combination therapies to improve patient outcomes in various cancer types.
Comprehensive research into plaque psoriasis and atopic dermatitis, with multiple trials testing new therapeutic agents and preventive approaches.
Focus on both treatment and prevention strategies for chronic skin conditions.
Innovative studies addressing ulcerative colitis and gastroparesis, testing novel therapeutic approaches and treatment combinations.
Trials aim to improve quality of life and treatment outcomes for patients with chronic digestive conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.